FASTinov, the global leader in rapid Antimicrobial Susceptibility Testing (AST),
Read More...FASTinov proudly announces its recent participation alongside Quilaban at the XI
Read More...May the new year bring you peace, good health, and success as we embark on a new
Read More...FASTinov and Quilaban are thrilled to announce the formal launch of the distribu
Read More...FASTinov announces the appointment of Mr. George Skinner as Director of Commerci
Read More...FASTinov announces that the prestigious oncology hospital IPO Porto has chosen t
Read More...© 2022 FASTinov S.A. - All Rights Reserved - Webdesign by Nova Agência
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |